KÜÇÜKTÜRKMEN, B. And BOZKIR, A. 2018. Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.44, no.2 , 306-315.

KÜÇÜKTÜRKMEN, B., & BOZKIR, A., (2018). Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.44, no.2, 306-315.

KÜÇÜKTÜRKMEN, BERRİN, And ASUMAN BOZKIR. "Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.44, no.2, 306-315, 2018

KÜÇÜKTÜRKMEN, BERRİN And BOZKIR, ASUMAN. "Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.44, no.2, pp.306-315, 2018

KÜÇÜKTÜRKMEN, B. And BOZKIR, A. (2018) . "Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.44, no.2, pp.306-315.

@article{article, author={BERRİN KÜÇÜKTÜRKMEN And author={ASUMAN BOZKIR}, title={Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2018, pages={306-315} }